|
1
|
Bao G, Qiao Q, Zhao H and He X: Prognostic
value of HMGB1 overexpression in resectable gastric
adenocarcinomas. World J Surg Oncol. 8:522010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chung HW, Lee SG, Kim H, et al: Serum high
mobility group box-1 (HMGB1) is closely associated with the
clinical and pathologic features of gastric cancer. J Transl Med.
7:382009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Akaike H, Kono K, Sugai H, et al:
Expression of high mobility group box chromosomal protein-1
(HMGB-1) in gastric cancer. Anticancer Res. 27:449–457.
2007.PubMed/NCBI
|
|
4
|
Sims GP, Rowe DC, Rietdijk ST, Herbst R
and Coyle AJ: HMGB1 and RAGE in inflammation and cancer. Annu Rev
Immunol. 28:367–388. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kang R, Zhang Q, Zeh HJ III, Lotze MT and
Tang D: HMGB1 in cancer: good, bad, or both? Clin Cancer Res.
19:4046–4057. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bianchi ME and Beltrame M: Upwardly mobile
proteins. Workshop: the role of HMG proteins in chromatin
structure, gene expression and neoplasia. EMBO Rep. 1:109–114.
2000. View Article : Google Scholar
|
|
7
|
Wang H, Bloom O, Zhang M, et al: HMG-1 as
a late mediator of endotoxin lethality in mice. Science.
285:248–251. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Scaffidi P, Misteli T and Bianchi ME:
Release of chromatin protein HMGB1 by necrotic cells triggers
inflammation. Nature. 418:191–195. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tang D, Kang R, Cheh CW, et al: HMGB1
release and redox regulates autophagy and apoptosis in cancer
cells. Oncogene. 29:5299–5310. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu L, Yang M, Kang R, et al:
HMGB1-induced autophagy promotes chemotherapy resistance in
leukemia cells. Leukemia. 25:23–31. 2011. View Article : Google Scholar
|
|
11
|
Mathew R, Karantza-Wadsworth V and White
E: Role of autophagy in cancer. Nat Rev Cancer. 7:961–967. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tang D, Kang R, Livesey KM, et al:
Endogenous HMGB1 regulates autophagy. J Cell Biol. 190:881–892.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu K, Huang J, Xie M, et al: MIR34A
regulates autophagy and apoptosis by targeting HMGB1 in the
retinoblastoma cell. Autophagy. 10:442–452. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pusterla T, Nèmeth J, Stein I, et al:
Receptor for advanced glycation endproducts (RAGE) is a key
regulator of oval cell activation and inflammation-associated liver
carcinogenesis in mice. Hepatology. 58:363–373. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Davalos AR, Kawahara M, Malhotra GK, et
al: p53-dependent release of Alarmin HMGB1 is a central mediator of
senescent phenotypes. J Cell Biol. 201:613–629. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Thorburn J, Horita H, Redzic J, Hansen K,
Frankel AE and Thorburn A: Autophagy regulates selective HMGB1
release in tumor cells that are destined to die. Cell Death Differ.
16:175–183. 2009. View Article : Google Scholar :
|
|
17
|
Smolarczyk R, Cichoń T, Matuszczak S, et
al: The role of Glycyrrhizin, an inhibitor of HMGB1 protein, in
anticancer therapy. Arch Immunol Ther Exp (Warsz). 60:391–399.
2012. View Article : Google Scholar
|
|
18
|
Taguchi A, Blood DC, del Toro G, et al:
Blockade of RAGE-amphoterin signalling suppresses tumour growth and
metastases. Nature. 405:354–360. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao M, Yang M, Yang L, et al: HMGB1
regulates autophagy through increasing transcriptional activities
of JNK and ERK in human myeloid leukemia cells. BMB Rep.
44:601–606. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
van Beijnum JR, Nowak-Sliwinska P, van den
Boezem E, Hautvast P, Buurman WA and Griffioen AW: Tumor
angiogenesis is enforced by autocrine regulation of high-mobility
group box 1. Oncogene. 32:363–374. 2013. View Article : Google Scholar
|
|
21
|
Volp K, Brezniceanu ML, Bosser S, et al:
Increased expression of high mobility group box 1 (HMGB1) is
associated with an elevated level of the antiapoptotic c-IAP2
protein in human colon carcinomas. Gut. 55:234–242. 2006.
View Article : Google Scholar
|
|
22
|
Cheng BQ, Jia CQ, Liu CT, et al: Serum
high mobility group box chromosomal protein 1 is associated with
clinicopathologic features in patients with hepatocellular
carcinoma. Dig Liver Dis. 40:446–452. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhan Z, Li Q, Wu P, et al:
Autophagy-mediated HMGB1 release antagonizes apoptosis of gastric
cancer cells induced by vincristine via transcriptional regulation
of Mcl-1. Autophagy. 8:109–121. 2012. View Article : Google Scholar
|
|
24
|
Brunelle JK, Ryan J, Yecies D, Opferman JT
and Letai A: MCL-1-dependent leukemia cells are more sensitive to
chemotherapy than BCL-2-dependent counterparts. J Cell Biol.
187:429–442. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kang R, Tang D, Lotze MT and Zeh HJ III:
AGER/RAGE-mediated autophagy promotes pancreatic tumorigenesis and
bioenergetics through the IL6-pSTAT3 pathway. Autophagy. 8:989–991.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Degenhardt K, Mathew R, Beaudoin B, et al:
Autophagy promotes tumor cell survival and restricts necrosis,
inflammation, and tumorigenesis. Cancer Cell. 10:51–64. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kang R, Livesey KM, Zeh HJ, Loze MT and
Tang D: HMGB1: a novel Beclin 1-binding protein active in
autophagy. Autophagy. 6:1209–1211. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang J, Zhu JS, Zhou Z, Chen WX and Chen
NW: Inhibitory effects of ethyl pyruvate administration on human
gastric cancer growth via regulation of the HMGB1-RAGE and Akt
pathways in vitro and in vivo. Oncol Rep. 27:1511–1519.
2012.PubMed/NCBI
|
|
29
|
Kang R, Tang D, Schapiro NE, et al: The
HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by
regulating mitochondrial bioenergetics. Oncogene. 33:567–577. 2014.
View Article : Google Scholar
|
|
30
|
Lin L, Zhong K, Sun Z, Wu G and Ding G:
Receptor for advanced glycation end products (RAGE) partially
mediates HMGB1-ERKs activation in clear cell renal cell carcinoma.
J Cancer Res Clin Oncol. 138:11–22. 2012. View Article : Google Scholar
|
